A total of 32 participants were enrolled:"Topical Spironolactone is the most commonlyused off-label
anti-androgen for the treatment of AGA. In the treatment of AGA, it acts by decreasing the production andcom-
petitively blocking the androgen receptor in the target tissue."
they were treated with Topical Spirono-
lactone solution 5% for six months.
Link alla studio completo: https://mjcu.journals.ekb.eg/article_110836_e38786e7057303e85115bcb620bdc96b.pdfResult: Our study shows that a topical spirono-lactone is better than topical finasteride in male and female group.
Conclusion: In this study, topical finasteride and Topical spironolactone are good options for management
of androgenic alopecia but topical spironolactone is better than topical finasteride with few side effects
when compared to oral administration.